Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

RenovoRx

Stock_Research_Today

Community Contributor

Revolutionizing Cancer Treatment

A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.

View narrative

US$4.20

75.0% undervalued

371.30%

Revenue growth p.a.

15 days ago

Apple

Investingwilly

Community Contributor

Apple: A Dying Star with an Overpriced Valuation

Intro Apple Inc. (AAPL) has long been one of the most beloved stocks in the market, celebrated for its sleek products and loyal customer base.

View narrative

US$177.34

19.7% overvalued

14.68%

Revenue growth p.a.

Updated

Avino Silver & Gold Mines

Agricola

Community Contributor

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Full disclosure. I am a shareholder at the time of writing this.

View narrative

CA$26.79

87.9% undervalued

78.01%

Revenue growth p.a.

15 days ago

RENK Group

Chris1

Community Contributor

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

In a renewed political landscape where a Trump administration adopts a more interventionist stance toward Ukraine, the United States sharply increases its military aid—providing advanced tank transmissions, power packs, and suspension systems. This pivot alleviates initial concerns among European allies, but it simultaneously reinforces the imperative for Europe to shore up its own defense capabilities.

View narrative

€69.87

24.5% undervalued

15.00%

Revenue growth p.a.

17 days ago

Load previous narratives

Cambium Networks

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

CN Wave 60 And PMP Platform Will Optimize Operations

Key Takeaways New product launches and sector expansion signal potential revenue growth and adoption in industrial and retail markets. Supply chain improvements and product line convergence indicate enhanced net margins and improved earnings through increased operational efficiencies.

View narrative

US$5.00

90.0% undervalued

14.58%

Revenue growth p.a.

14 days ago

CXApp

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

We Will Transition To AI Driven SaaS Excellence

Key Takeaways CXApp's shift to a SaaS AI model aims for higher recurring revenues and improved net margins through its subscription-based approach. Strategic hires and product innovations position CXApp to strengthen technological leadership and capture growth in the employee experience market.

View narrative

US$4.00

72.0% undervalued

42.53%

Revenue growth p.a.

14 days ago

CurveBeam AI

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

Vendor Financing And HiRise Submission Will Unlock European Markets

Key Takeaways Strong growth in purchase orders and a new financing facility are expected to enhance revenue and facilitate market expansion. Progressing towards cash flow positivity and revenue expansion via product innovation and new SaaS offerings could establish leadership in the market.

View narrative

AU$0.18

46.7% undervalued

86.30%

Revenue growth p.a.

14 days ago

Beyond Air

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

The Next-Generation LungFit PH System Will Open New Markets

Key Takeaways International revenue could significantly impact growth due to CE Mark approval and distribution partnerships, especially in the EU. Efforts to control costs have lowered cash burn, potentially improving net margins if sustained.

View narrative

US$2.25

91.8% undervalued

140.78%

Revenue growth p.a.

14 days ago

tinyBuild

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

Data Driven Game Investments Will Secure Future Momentum

Key Takeaways Focus on cash generation and high-potential games enhances cost management and strengthens the game pipeline, boosting future revenue and earnings. Diversified revenue through own IP development and multimedia expansions supports stable growth and improved margins.

View narrative

UK£0.07

25.0% undervalued

7.24%

Revenue growth p.a.

14 days ago

Integrum

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

US Sales Focus And Axor II Will Boost Market Outlook

Key Takeaways Strategic focus on U.S. market growth and marketing optimization is expected to boost revenue and improve net margins. Near-term revenue prioritization and leadership changes aim to enhance market adoption and drive shareholder value.

View narrative

SEK 39.00

57.3% undervalued

35.92%

Revenue growth p.a.

14 days ago

Lisata Therapeutics

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

Certepetide Advancements And Regulatory Approvals Will Set New Care Standards

Key Takeaways Advancements in certepetide and regulatory achievements could expedite market entry, fostering revenue growth and enhancing treatment standards. Strategic partnerships and diversified applications beyond oncology offer new revenue streams and market expansion opportunities, potentially improving margins.

View narrative

US$17.00

87.2% undervalued

49.38%

Revenue growth p.a.

14 days ago

Mogo

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

We Will Elevate Wealth And Payments With Intelligent Investing

Key Takeaways Mogo's focus on scaling wealth and payments enhances market share, while exiting low-margin operations concentrates resources on high-margin growth areas. AI-driven Intelligent Investing could disrupt traditional wealth models with low-fee structures, enhancing net margins and boosting earnings in high-margin segments.

View narrative

CA$3.00

40.3% undervalued

26.90%

Revenue growth p.a.

14 days ago

Fathom Holdings

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

Acquisitions And Mortgage Title Services Will Expand Market Presence

Key Takeaways Fathom Holdings aims for sustainable positive adjusted EBITDA by 2025, powered by revenue growth and cost management. New acquisitions and expanding ancillary services could significantly boost revenue and enhance market presence.

View narrative

US$1.50

17.3% undervalued

22.71%

Revenue growth p.a.

14 days ago

Community

Weekly Picks

Revolutionizing Cancer Treatment

Apple: A Dying Star with an Overpriced Valuation

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

CN Wave 60 And PMP Platform Will Optimize Operations

We Will Transition To AI Driven SaaS Excellence

Vendor Financing And HiRise Submission Will Unlock European Markets

The Next-Generation LungFit PH System Will Open New Markets

Data Driven Game Investments Will Secure Future Momentum

US Sales Focus And Axor II Will Boost Market Outlook

Certepetide Advancements And Regulatory Approvals Will Set New Care Standards

We Will Elevate Wealth And Payments With Intelligent Investing

Acquisitions And Mortgage Title Services Will Expand Market Presence

Value any company in seconds

Popular companies

Community

Weekly Picks

Revolutionizing Cancer Treatment

Apple: A Dying Star with an Overpriced Valuation

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

Community Investing Ideas

CN Wave 60 And PMP Platform Will Optimize Operations

We Will Transition To AI Driven SaaS Excellence

Vendor Financing And HiRise Submission Will Unlock European Markets

The Next-Generation LungFit PH System Will Open New Markets

Data Driven Game Investments Will Secure Future Momentum

US Sales Focus And Axor II Will Boost Market Outlook

Certepetide Advancements And Regulatory Approvals Will Set New Care Standards

We Will Elevate Wealth And Payments With Intelligent Investing

Acquisitions And Mortgage Title Services Will Expand Market Presence

Value any company in seconds

Popular companies